The estimated Net Worth of Michael J Berendt is at least $10.8 Milion dollars as of 13 August 2021. Michael Berendt owns over 806 units of Waters stock worth over $5,374,382 and over the last 21 years he sold WAT stock worth over $5,113,676. In addition, he makes $306,363 as Independent Director at Waters.
Sign up
Michael Berendt WAT stock SEC Form 4 insiders trading
Michael has made over 22 trades of the Waters stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 806 units of WAT stock worth $324,915 on 13 August 2021.
The largest trade he's ever made was selling 7,000 units of Waters stock on 20 February 2014 worth over $796,460. On average, Michael trades about 1,774 units every 94 days since 2004. As of 13 August 2021 he still owns at least 16,449 units of Waters stock.
You can see the complete history of Michael Berendt stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Berendt biography
Dr. Michael Joseph Berendt, Ph.D., is Independent Director of Waters Corporation. Since December 2016, Dr. Berendt has been a life sciences industry consultant. From November 2013 to November 2016, Dr. Berendt was the Chief Executive Officer and Chief Scientist of Telesta Therapeutics. From July 2011 to November 2013, Dr. Berendt was a life sciences industry consultant. From March 2006 to July 2011, Dr. Berendt served as the President and Chief Executive Officer of Aegera Therapeutics Inc. From August 2004 to December 2005, Dr. Berendt served as Managing Director of Research Corporation Technologies, Inc. From November 2000 to August 2004, Dr. Berendt served as Managing Director of AEA Investors LP. Dr. Berendt also worked for 18 years, from 1982 to 2000, in the pharmaceutical industry where he served in a number of senior management positions including Senior Vice President of Research for the Pharmaceutical Division of Bayer Corporation, and a Group Director of Drug Discovery at Pfizer, Inc. Dr. Berendt’s experience in the pharmaceutical industry both from a management and a scientific perspective provides unique technical insight to the Waters Board. In addition, Dr. Berendt’s years of experience as a Chief Executive Officer and as a senior financial executive, affords the Waters Board the benefit of his financial and business strategy skills.
What is the salary of Michael Berendt?
As the Independent Director of Waters, the total compensation of Michael Berendt at Waters is $306,363. There are 17 executives at Waters getting paid more, with Robert Carson having the highest compensation of $3,781,720.
How old is Michael Berendt?
Michael Berendt is 70, he's been the Independent Director of Waters since 1998. There are no older and 20 younger executives at Waters.
What's Michael Berendt's mailing address?
Michael's mailing address filed with the SEC is 34, Maple Street, Milford, Worcester County, Massachusetts, 01757, United States.
Insiders trading at Waters
Over the last 22 years, insiders at Waters have traded over $28,041,740 worth of Waters stock and bought 4,185 units worth $1,330,824 . The most active insiders traders include Joshua Bekenstein, Edward Conard a Mark P Vergnano. On average, Waters executives and independent directors trade stock every 22 days with the average trade being worth of $5,835,071. The most recent stock trade was executed by Richard H Fearon on 28 May 2024, trading 1,000 units of WAT stock currently worth $332,900.
What does Waters do?
waters corporation (nyse: wat), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years. with approximately 7,000 employees worldwide, waters operates directly in 31 countries, including 15 manufacturing facilities, and with products available in more than 100 countries. waters corporation's businesses include waters, ta instruments, vicam, era, and nonlinear dynamics. waters creates business advantages for laboratory-dependent organizations by delivering ultra performance liquid chromatography (uplc), high-performance liquid chromatography (hplc), chromatography columns and chemistry products, mass spectrometry systems, laboratory informatics solutions, and comprehensive service programs to enable significant advancement in healthcare delivery, environmental management, food safety, and water quality. ta instruments' thermal analysis, rheometry
What does Waters's logo look like?
Complete history of Michael Berendt stock trades at Waters
Waters executives and stock owners
Waters executives and other stock owners filed with the SEC include:
-
Robert Carson,
Senior Vice President - Corporate Development -
Ian King,
Senior Vice President - Global Products -
Elizabeth Rae,
Senior Vice President - Global Human Resources -
Dr. Udit Batra Ph.D.,
Pres, CEO & Director -
Christopher O'Connell,
Chairman of the Board -
Keeley Aleman,
Senior Vice President, General Counsel and Corporate Secretary -
Dr. Michael C. Harrington Ph.D.,
Consultant -
Ian S. King,
Consultant -
Jonathan M. Pratt,
Sr. VP of Waters Division -
Jonathan Pratt,
Senior Vice President and President of TA Instruments -
Sherry Buck,
Chief Financial Officer, Senior Vice President -
Michael Harrington,
Senior Vice President - Global Markets -
JoAnn Reed,
Independent Director -
Thomas Salice,
Lead Independent Director -
Christopher Kuebler,
Independent Director -
Flemming Ornskov,
Independent Director -
Edward Conard,
Independent Director -
Michael Berendt,
Independent Director -
Gary Hendrickson,
Independent Director -
Linda Baddour,
Independent Director -
Bryan Brokmeier,
Senior Director, Investor Relations -
Udit Batra,
President, Chief Executive Officer, Director -
Kristen Garvey,
VP of Corp. Communications -
Kevin Kempskie,
Sr. Director of PR -
Keeley A. Aleman,
Sr. VP, Gen. Counsel & Corp. Sec. -
Caspar Tudor,
Mang. of Investor Relations -
Daniel J. Welch,
Sr. VP of Global Operations -
Amol Chaubal,
Sr. VP & CFO -
Amol Chaubal,
SVP & Chief Financial Officer -
Jianqing Bennett,
SVP TA Instruments Division -
Daniel J. Welch,
SVP Global Operations -
Joshua Bekenstein,
Director -
Michael F Silveira,
VP, Corporate Controller -
Laurie H M.D. Glimcher,
Director -
William J Miller,
Director -
Eugene G Cassis,
Chief Financial Officer -
Arthur G Caputo,
President -
Douglas A Berthiaume,
Chairman, President and CEO -
Terrence P Kelly,
President, TA Instruments -
David Terricciano,
VP of Operations -
Rohit Khanna,
Sr VP, Applied Technology -
John A Ornell,
CFO -
Francis Kim,
SVP Global Operations -
Robert L Iii Carpio,
SVP, Waters Division -
William Curry,
-
Brian K Mazar,
Sr. VP -
Philip Caldwell,
Director -
John R Nelson,
EVP -
Laurie H Md Glimcher,
Director -
Mark T Beaudouin,
SVP and General Counsel -
Pearl S Huang,
Director -
Belinda Hyde,
SVP, Global Human Resources -
Wei Jiang,
Director -
John M Ballbach,
Director -
Mark P Vergnano,
Director -
Daniel J. Brennan,
Director -
Richard H Fearon,
Director -
Heather Knight,
Director